Discontinuation of vasopressin before norepinephrine increases the incidence of hypotension in patients recovering from septic shock: A retrospective cohort study

Journal of Critical Care

Volumn 25, Issue 2, 2010, Pages 362.e7-362.e11

  Bauer, Seth R ^a   Aloi, Joseph J ^b   Ahrens, Christine L ^a   Yeh, Jun Yen ^a   Culver, Daniel A ^a   Reddy, Anita J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b FLETCHER ALLEN HEALTH CARE   (United States)

Author keywords

Convalescence; Hypotension; Norepinephrine; Septic shock; Treatment efficacy; Vasopressin

Indexed keywords

CORTICOSTEROID; NORADRENALIN; VASOPRESSIN;

ADULT; ARTICLE; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPOTENSION; INCIDENCE; INTENSIVE CARE UNIT; MALE; OUTCOME ASSESSMENT; RETROSPECTIVE STUDY; SEPTIC SHOCK; TERTIARY HEALTH CARE;

EID: 77953293999     PISSN: 08839441     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrc.2009.10.005     Document Type: Article

References (13)

1. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36:296-327.
2. Landry D.W., Oliver J.A. The pathogenesis of vasodilatory shock. N Engl J Med 2001, 345:588-595.
3. Bone R.C., Sibbald W.J., Sprung C.L. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992, 101:1481-1483.
4. Knaus W.A., Draper E.A., Wagner D.P., et al. APACHE II: a severity of disease classification system. Crit Care Med 1985, 13:818-829.
5. Vincent J.L., Moreno R., Takala J., et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996, 22:707-710.
6. Landry D.W., Levin H.R., Gallant E.M., et al. Vasopressin deficiency contributes to the vasodilation of septic shock. Circulation 1997, 95:1122-1125.
7. Tsuneyoshi I., Yamada H., Kakihana Y., et al. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 2001, 29:487-493.
8. Malay M.B., Ashton R.C., Landry D.W., et al. Low-dose vasopressin in the treatment of vasodilatory septic shock. J Trauma 1999, 47:699-703. discussion 703-695.
9. Morales D.L., Garrido M.J., Madigan J.D., et al. A double-blind randomized trial: prophylactic vasopressin reduces hypotension after cardiopulmonary bypass. Ann Thorac Surg 2003, 75:926-930.
10. Russell J.A., Walley K.R., Singer J., et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008, 358:877-887.
11. Russell J.A., Walley K.R., Gordon A.C., et al. Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shock. Crit Care Med 2009, 37:811-818.
12. Barrett L.K., Singer M., Clapp L.H. Vasopressin: mechanisms of action on the vasculature in health and in septic shock. Crit Care Med 2007, 35:33-40.
13. Guillon G., Trueba M., Joubert D., et al. Vasopressin stimulates steroid secretion in human adrenal glands: comparison with angiotensin-II effect. Endocrinology 1995, 136:1285-1295.